Last reviewed · How we verify

NCT04013399

Obstructive Sleep Apnea Treatment and Insulin Sensitivity in Pregnancy

Withdrawn NA Last updated 27 July 2023
What this trial tests

NA trial testing Continuous Positive Airway Pressure in Obstructive Sleep Apnea. Withdrawn.

Timeline
1 July 2020
Primary endpoint
30 September 2022
30 March 2023

Quick facts

Lead sponsorBarnes-Jewish Hospital
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Start date1 July 2020
Primary completion30 September 2022
Estimated completion30 March 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Barnes-Jewish Hospital

Who can join

Adults 20 to 39, female only, with Obstructive Sleep Apnea or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the effect of treatment of obstructive sleep apnea on insulin sensitivity in pregnant women. Women in their third trimester of pregnancy will be randomized to receive treatment or no treatment for one month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Continuous Positive Airway Pressure

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Barnes-Jewish Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing